Tag: IBD-
Interventions That Boost Mood Cut Inflammation With IBD
Small effects seen for improved fecal calprotectin and C-reactive protein
Higher Use of Any Rx Medications Seen Years Before IBD Diagnosis
Findings strongest for Crohn disease with ties to multisystem organ involvement
Persistent Fluorinated Chemicals Tied to Higher Risk for Inflammatory Bowel Disease
Odds for Crohn disease and ulcerative colitis increased with higher serum perfluoroalkyl and polyfluoroalkyl substance levels up to 10 years before diagnosis
Malnutrition Often Seen in Patients Treated for IBD
Active disease, smoking tied to higher likelihood of screening positive
Inflammatory Bowel Disease Phenotypes Vary by Race, Birthplace
Foreign-born patients more likely to be diagnosed with UC and less likely to have early-onset disease, severe disease
Changes in Biochemical, Hematological Parameters Seen Before IBD Diagnosis
Widespread significant changes identified that occur up to eight years before Crohn disease, three years before ulcerative colitis
Histologic Inflammation With IBD Tied to Serious Infections
Authors say achieving histologic remission for both Crohn disease and ulcerative colitis may reduce the risk for serious infections
Higher Visceral Adipose Tissue May Need Higher Infliximab Levels for IBD Remission
Both visceral adipose percentage and infliximab levels independently tied to steroid-free deep remission
Inflammatory Bowel Disease Increases Risk for Later Arrhythmias
Findings seen for inflammatory bowel disease overall, as well as individual diseases
ACG: Prophylactic Low-Dose Aspirin in Pregnancy Does Not Increase IBD Activity
Findings seen among pregnant patients with inflammatory bowel disease
